Education
About Us
Working with TipRanks
Follow Us
Sensei Biotherapeutics, Inc. (SNSE)
:SNSE
SNSE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.38 - $1.94
Previous CloseN/A
Volume8.76M
Average Volume (3M)132.85K
Market Cap
$10.71M
Enterprise Value-$27.49M
Total Cash (Recent Filing)$10.96M
Total Debt (Recent Filing)$5.64M
Price to Earnings (P/E)―
Beta1.24
Next Earnings
May 13, 2025EPS Estimate
-0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.19
Shares Outstanding25,151,379
10 Day Avg. Volume77,336
30 Day Avg. Volume132,850
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)30.56
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market Cap-2.57
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit48.15
Enterprise Value/Ebitda0.95
Forecast
1Y Price Target
$4.00Price Target Upside788.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Sensei Biotherapeutics News
PremiumCompany Announcements
Sensei Biotherapeutics Q3 2024 Results and Strategic Moves
PremiumCompany Announcements
Sensei Biotherapeutics Appoints New Financial Chief
PremiumCompany Announcements
Dr. Jessie English Resigns from Sensei Biotherapeutics Board---
Bulls Say, Bears Say
Bulls Say
Analyst RecommendationAnalyst reiterates a Buy rating for Sensei Biotherapeutics with a price target of $4, based on probability-adjusted revenue forecasts for SNS-101.
Clinical TrialsSNS-101 continues to be well tolerated in ongoing clinical trials, which is promising for its future development.
Bears Say
Data Update DelayThe anticipated data update for the SNS-101 study has been delayed to 1H25, as the company seeks more duration data.
---
Ownership Overview
31.63% Insiders
3.21% Mutual Funds
4.68% Other Institutional Investors
58.16% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SNSE FAQ
What was Sensei Biotherapeutics, Inc.’s price range in the past 12 months?
Sensei Biotherapeutics, Inc. lowest stock price was $0.38 and its highest was $1.94 in the past 12 months.
What is Sensei Biotherapeutics, Inc.’s market cap?
Sensei Biotherapeutics, Inc.’s market cap is $10.71M.
When is Sensei Biotherapeutics, Inc.’s upcoming earnings report date?
Sensei Biotherapeutics, Inc.’s upcoming earnings report date is May 13, 2025 which is in 62 days.
How were Sensei Biotherapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Sensei Biotherapeutics, Inc. overvalued?
According to Wall Street analysts Sensei Biotherapeutics, Inc.’s price is currently Undervalued.
Does Sensei Biotherapeutics, Inc. pay dividends?
Sensei Biotherapeutics, Inc. does not currently pay dividends.
What is Sensei Biotherapeutics, Inc.’s EPS estimate?
Sensei Biotherapeutics, Inc.’s EPS estimate is -0.28.
How many shares outstanding does Sensei Biotherapeutics, Inc. have?
Sensei Biotherapeutics, Inc. has 25,151,379 shares outstanding.
What happened to Sensei Biotherapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sensei Biotherapeutics, Inc.?
Currently, no hedge funds are holding shares in SNSE
---
Company Description
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics (SNSE) is a clinical-stage biopharmaceutical company focused on developing next-generation immuno-oncology therapies. The company specializes in the discovery and development of biologics designed to modulate the immune system to treat cancer. Sensei Biotherapeutics leverages its proprietary platform to create innovative therapeutics aimed at overcoming the limitations of current cancer treatments.
---
SNSE Stock 12 Month Forecast
Average Price Target
$4.00
▲(788.89% Upside)
Technical Analysis
Best Analysts Covering SNSE
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-33.96%
reiterated a buy rating 2 months ago
Copying Edward White's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -33.96% per trade.
---